News
Important Only
Other
D Boral Arc Acquisition I Corp Files Form S-1 With SEC - SEC Filing
April 29 (Reuters) - SEC Filing:D BORAL ARC ACQUISITION I CORP - FILES FORM S-1 WITH SEC - SEC FILINGBLANK CHECK COMPANY D. BORAL ARC ACQUISITION I CORP FILES FOR IPO OF UP TO $250 MILLION - SEC FILINGD. BORAL ARC ACQUISITION I CORP - INTEND TO APPLY TO HAVE UNITS LISTED ON NASDAQ GLOBAL MARKETD. BO...Reuters
Tue, Apr 29
Stocks
OREO gets its most epic dunk ever – in the Milky Way
JAKARTA, Indonesia, April 29, 2025 /PRNewswire/ -- OREO, cherished worldwide for its special bond with milk as epitomized by the "OREO dunk", has reimagined this classic ritual. To introduce its limited-edition Space Dunk cookies in Southeast Asia, OREO took a cosmic leap, dunking not...PR Newswire
Tue, Apr 29
Stocks
Chipotle's Sales Just Dropped for the First Time Since 2020. What Should Investors Do Now?
Whether it's for a burrito, guacamole, or something else, diners have consistently gone out to eat at Chipotle Mexican Grill (NYSE: CMG) more and more over the last 10 years. Of course, there was an exception to this trend at the outset of the COVID-19 pandemic -- comparable sales were down nearly 1...The Motley Fool
Tue, Apr 29
Stocks
Can Shiba Inu Reach $1 in 2030?
To say that Shiba Inu has been on a wildly volatile journey would probably be putting it lightly. The meme cryptocurrency, inspired by its predecessor Dogecoin, absolutely skyrocketed in late 2021 to hit its peak in October that year. But it's been a bumpy downward trend since. As of April 25, this ...The Motley Fool
Tue, Apr 29
Other
Surf Air Mobility Files Prospectus For Registration Of Resale By Selling Stockholder
April 29 (Reuters) - Surf Air Mobility Inc SRFM.N:SURF AIR MOBILITY FILES PROSPECTUS RELATES TO REGISTRATION OF RESALE BY SELLING STOCKHOLDER OF UP TO 3.4 MILLION SHARES OF COMMON STOCKSource text: [ID:n0000950170-25-059474]Reuters
Tue, Apr 29
Stocks
Honeywell rises in early trade after Q1 beat
** Honeywell's shares HON.O up 5% to $210.71 premarket** Industrial conglomerate's Q1 adjusted EPS of $2.51 beats estimates of $2.21, while sales of $9.82 billion also top estimates of $9.59 billion, per LSEG data** Co raises 2025 adjusted EPS forecast to $10.20 - $10.50 from $10.10 - $10.50...Reuters
Tue, Apr 29
Other
Polaris Says Withdrawing Full Year 2025 Company Sales And Adjusted Earnings Guidance
April 29 (Reuters) - Polaris Inc PII.N:: WITHDRAWING FULL YEAR 2025 COMPANY SALES AND ADJUSTED EARNINGS GUIDANCEOUTLOOK Q2 SALES GUIDANCE OF $1.6 BILLION TO $1.8 BILLIONQ2 REVENUE VIEW $1.85 BILLION -- LSEG IBES DATAPOLARIS SAYS IS TAKING ACTIONS TO REDUCE CHINA SOURCING BY 30% BY YEAR-END - PRESEN...Reuters
Tue, Apr 29
Other
Stealth BioTherapeutics Announces Delay In FDA Action Date For Barth Syndrome Application
April 29 (Reuters) - STEALTH BIOTHERAPEUTICS ANNOUNCES DELAY IN FDA ACTION DATE FOR BARTH SYNDROME APPLICATIONSTEALTH: HOPE TO GAIN MORE INFORMATION ON REVISED ACTION DATE FROM FDA IN COMING DAYSReuters
Tue, Apr 29
Commodities
Burkina faso to nationalise more industrial mines, prime minister says
April 29 (Reuters) - Burkina Faso plans to take control of more foreign-owned industrial mines, the country's prime minister said, as the West African country seeks a bigger share of revenue from its national resources. Prime Minister Jean Emmanuel Ouédraogo said Burkina Faso planned to contin...Reuters
Tue, Apr 29
Stocks
Spotify falls on lower-than-expected Q2 operating income forecast
** Shares of Swedish audio streaming giant Spotify Technology SPOT.N fall 6.3% to $560 premarket ** SPOT forecast operating income of 539 mln euros ($614.24 mln) for Q2, below estimates of 557.5 mln euros - data compiled by LSEG** Co expects Q2 monthly active users of 689 mln, compared with estimate...Reuters
Tue, Apr 29
Stocks
Abeona rises on FDA approval for skin disorder therapy
** Shares of drugmaker Abeona Therapeutics ABEO.O up 12.7% at $6.03 premarket** ABEO says the U.S. FDA has approved its gene therapy for a rare skin disorder** The gene therapy, called Zevaskyn, is approved to treat adult and pediatric patients with recessive dystrophic epidermolysis bullosa** The c...Reuters
Tue, Apr 29
Other
INSIGHT-A tale of two Syrias: free-market opening sows resentment of new rulers
Syria's free-market opening benefits traders in former rebel stronghold Idlib In Damascus, some businesses used to Assad's protectionism fear openingEconomic opening has fuelled some resentment of Idlib's strength UN official warns Syria will need some tariffs to protect its industry By ...Reuters
Tue, Apr 29
Other
Gates, others launch $500 million maternal, newborn health fund, bucking aid cuts trend
By Jennifer Rigby LONDON, April 29 (Reuters) - A group of philanthropies including the Gates Foundation has set up a fund backed with nearly $500 million to help save the lives of newborn babies and mothers in sub-Saharan Africa, standing out against a bleak global health funding landscape.The Be...Reuters
Tue, Apr 29
Stocks
AT&T Stock Is Back to Multiyear Highs. Time to Buy?
AT&T (NYSE: T) stock appears to be benefiting from its most promising outlook in years. Earlier in the decade, the stock suffered after the company slashed its dividend in 2022 following 35 consecutive years of increases.However, the telecom stock now trades at its highest levels since 2019, and the...The Motley Fool
Tue, Apr 29
Other
National Vision Appoints Alex Wilkes As CEO
April 29 (Reuters) - National Vision Holdings Inc EYE.O:NATIONAL VISION APPOINTS ALEX WILKES AS CEONATIONAL VISION HOLDINGS INC - APPOINTS ALEX WILKES AS CEO EFFECTIVE AUGUST 1, 2025NATIONAL VISION HOLDINGS INC - READE FAHS TO ASSUME EXECUTIVE CHAIRMAN POSITIONNATIONAL VISION HOLDINGS INC - ALEX WIL...Reuters
Tue, Apr 29
Other
US FDA Approves ZEVASKYN, First And Only Cell-Based Gene Therapy For Patients With Recessive Dystrophic Epidermolysis Bullosa
April 29 (Reuters) - Abeona Therapeutics Inc ABEO.O:U.S. FDA APPROVES ZEVASKYN™ (PRADEMAGENE ZAMIKERACEL), THE FIRST AND ONLY CELL-BASED GENE THERAPY FOR PATIENTS WITH RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB)ABEONA THERAPEUTICS INC - ZEVASKYN TO BE AVAILABLE THROUGH QUALIFIED TREATMENT CENT...Reuters
Tue, Apr 29
